FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jeffrey Lieberman

Research Profile

Disorders

Chemicals & Drugs

Physiology

Genes & Molecular Sequences

Living Beings

Concepts & Ideas

Co-author Network

Publications

TOP 3
Arun K Tiwari; Caroline Weber; Clement Zai; Eva J Brandl; Margaret K Hahn; James L Kennedy; Jeffrey A Lieberman; Olga Likhodi; Herbert Y Meltzer; Daniel J Müller
Association of a functional polymorphism in neuropeptide y with antipsychotic-induced weight gain in schizophrenia patients.
Gwyneth Zai; Nabilah I Chowdhury; Jeffrey A Lieberman; Herbert Y Meltzer; Daniel J Müller; Steven G Potkin; Renan Souza; Arun K Tiwari; Clement Zai; James L Kennedy
The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gain.
E J Brandl; S Büttner; S Ehrlich; C Frydrychowicz; James L Kennedy; W Kitzrow; T A P Lett; Jeffrey A Lieberman; Herbert Y Meltzer; Daniel J Müller; A K Tiwari; Imke Puls
Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jeffrey Lieberman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Arun K Tiwari; Caroline Weber; Clement Zai; Eva J Brandl; Margaret K Hahn; James L Kennedy; Jeffrey A Lieberman; Olga Likhodi; Herbert Y Meltzer; Daniel J Müller
Association of a functional polymorphism in neuropeptide y with antipsychotic-induced weight gain in schizophrenia patients.
Journal of clinical psychopharmacology 2013;33(1):11-7.
2012: Gwyneth Zai; Nabilah I Chowdhury; Jeffrey A Lieberman; Herbert Y Meltzer; Daniel J Müller; Steven G Potkin; Renan Souza; Arun K Tiwari; Clement Zai; James L Kennedy
The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gain.
Progress in neuro-psychopharmacology & biological psychiatry 2012;39(1):96-101.
2012: E J Brandl; S Büttner; S Ehrlich; C Frydrychowicz; James L Kennedy; W Kitzrow; T A P Lett; Jeffrey A Lieberman; Herbert Y Meltzer; Daniel J Müller; A K Tiwari; Imke Puls
Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain.
Progress in neuro-psychopharmacology & biological psychiatry 2012;38(2):134-41.
2012: Daniel J Müller; Jessica E Sturgess; Arun K Tiwari; Clement Zai; Eva J Brandl; Rudi Hwang; James L Kennedy; Jeffrey A Lieberman; Margaret A Richter
The AmpliChip® CYP450 test and response to treatment in schizophrenia and obsessive compulsive disorder: a pilot study and focus on cases with abnormal CYP2D6 drug metabolism.
Genetic testing and molecular biomarkers 2012;16(8):897-903.
2012: Yuko Hirata; Jeffrey A Lieberman; Herbert Y Meltzer; Renan Souza; Clement Zai; James L Kennedy
Association study of GRIK1 gene polymorphisms in schizophrenia: case-control and family-based studies.
Human psychopharmacology 2012;27(4):345-51.
2012: Arun K Tiwari; A N Voineskos; Clement Zai; Jeffrey A Lieberman; Olga Likhodi; Herbert Y Meltzer; Daniel J Müller; Steven G Potkin; Gary Remington; James L Kennedy
Association study of cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia.
The pharmacogenomics journal 2012;12(3):260-6.
2012: Rudi Hwang; Daniel Felsky; Jeffrey A Lieberman; Herbert Y Meltzer; Gabriel Oh; Steven G Potkin; Eli Remington; Renan Souza; Arun K Tiwari; Ryan P Tong; Tessa Wallace; Clement Zai; James L Kennedy
Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia: replication and exploration.
Progress in neuro-psychopharmacology & biological psychiatry 2012;37(1):62-75.
2012: Renan Souza; Arun K Tiwari; Rolando B Ceddia; Nabilah I Chowdhury; James L Kennedy; Jeffrey A Lieberman; Herbert Y Meltzer; Daniel J Müller
Association study between variants of AMP-activated protein kinase catalytic and regulatory subunit genes with antipsychotic-induced weight gain.
Journal of psychiatric research 2012;46(4):462-8.
2012: Daniel J Müller; E Remington; S Shaikh; M Sicard; Renan Souza; Arun K Tiwari; Clement Zai; Tamara Arenovich; N Freeman; A Heinz; Rudi Hwang; Jeffrey A Lieberman; Olga Likhodi; Herbert Y Meltzer; James L Kennedy
Systematic analysis of dopamine receptor genes (DRD1-DRD5) in antipsychotic-induced weight gain.
The pharmacogenomics journal 2012;12(2):156-64.
2011: Tristram A P Lett; Jeffrey A Lieberman; Herbert Y Meltzer; Steven G Potkin; Arun K Tiwari; Aristotle N Voineskos; James L Kennedy; Daniel J Müller
The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine response.
Schizophrenia research 2011;132(2-3):121-4.
2011: Renan Souza; Daniela V F Rosa; Marco A Romano-Silva; Mei Zhen; Herbert Y Meltzer; Jeffrey A Lieberman; Gary Remington; James L Kennedy; Albert H C Wong
Lack of association of NALCN genetic variants with schizophrenia.
Psychiatry research 2011;185(3):450-2.
2011: Renan Souza; Aristotle N Voineskos; Jeffrey A Lieberman; Herbert Y Meltzer; Gary Remington; James L Kennedy
Prolactin as a biomarker for treatment response and tardive dyskinesia in schizophrenia subjects: old thoughts revisited from a genetic perspective.
Human psychopharmacology 2011;26(1):21-7.
2010: Arun K Tiwari; Jarlath B Rodgers; Michelle Sicard; Clement Zai; Olga Likhodi; Natalie Freeman; Herbert Y Meltzer; Jeffrey A Lieberman; James L Kennedy; Daniel J Müller
Association study of polymorphisms in cholecystokinin gene and its receptors with antipsychotic induced weight gain in schizophrenia patients.
Progress in neuro-psychopharmacology & biological psychiatry 2010;34(8):1484-90.
2010: Renan Souza; Herbert Y Meltzer; Jeffrey A Lieberman; Bernard Le Foll; James L Kennedy
Influence of neurexin 1 (NRXN1) polymorphisms in clozapine response.
Human psychopharmacology 2010;25(7-8):582-5.
2010: Gabriela Novak; Clement Zai; M Mirkhani; Sajid Shaikh; John B Vincent; Herbert Y Meltzer; Jeffrey A Lieberman; John Strauss; D Lévesque; James L Kennedy; Bernard Le Foll
Replicated association of the NR4A3 gene with smoking behaviour in schizophrenia and in bipolar disorder.
Genes, brain, and behavior 2010;9(8):910-7.
2010: Renan Souza; Gary Remington; Nabilah I Chowdhury; Matthew K Lau; Aristotle N Voineskos; Jeffrey A Lieberman; Herbert Y Meltzer; James L Kennedy
Association study of the GSK-3B gene with tardive dyskinesia in European Caucasians.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2010;20(10):688-94.
2010: Clement Zai; Arun K Tiwari; Daniel J Müller; Vincenzo De Luca; Takahiro Shinkai; Sajid Shaikh; Xingqun Ni; David Sibony; Aristotle N Voineskos; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; Gary Remington; James L Kennedy
The catechol-O-methyl-transferase gene in tardive dyskinesia.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2010;11(6):803-12.
2010: Renan Souza; Vincenzo De Luca; Herbert Y Meltzer; Jeffrey A Lieberman; James L Kennedy
Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2010;13(6):793-8.
2010: Renan Souza; Vincenzo De Luca; Gary Remington; Jeffrey A Lieberman; Herbert Y Meltzer; James L Kennedy; Albert H C Wong
Glial cell line-derived neurotrophic factor receptor alpha 2 (GFRA2) gene is associated with tardive dyskinesia.
Psychopharmacology 2010;210(3):347-54.
2010: Rudi Hwang; Clement Zai; Arun K Tiwari; Daniel J Müller; Maria J Arranz; A G Morris; P J McKenna; J Munro; Steven G Potkin; Jeffrey A Lieberman; Herbert Y Meltzer; James L Kennedy
Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant.
The pharmacogenomics journal 2010;10(3):200-18.
2010: Arun K Tiwari; Clement Zai; Olga Likhodi; Annika Lisker; Deepika Singh; Renan Souza; Poonam Batra; Syed Zaidi; Sheng Chen; Fang Liu; Imke Puls; Herbert Y Meltzer; Jeffrey A Lieberman; James L Kennedy; Daniel J Müller
A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2010;35(6):1315-24.
2010: Arun K Tiwari; Clement C Zai; Herbert Y Meltzer; Jeffrey A Lieberman; Daniel J Müller; James L Kennedy
Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients.
Human psychopharmacology 2010;25(3):253-9.
2010: Gabriela Novak; Alexandra Gallo; Clement Zai; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; Aristotle N Voineskos; Gary Remington; James L Kennedy; Daniel Levesque; Bernard Le Foll
Association of the orphan nuclear receptor NR4A1 with tardive dyskinesia.
Psychiatric genetics 2010;20(1):39-43.
2010: Clement Zai; Arun K Tiwari; Vincenzo S Basile; Vincenzo De Luca; Daniel J Müller; Aristotle N Voineskos; Gary Remington; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; James L Kennedy
Oxidative stress in tardive dyskinesia: genetic association study and meta-analysis of NADPH quinine oxidoreductase 1 (NQO1) and Superoxide dismutase 2 (SOD2, MnSOD) genes.
Progress in neuro-psychopharmacology & biological psychiatry 2010;34(1):50-6.
2009: Renan Souza; Maria Tampakeras; Vincenzo S Basile; Takahiro Shinkai; Daniela V F Rosa; Steve Potkin; Herbert Y Meltzer; Jeffrey A Lieberman; Marco A Romano-Silva; James L Kennedy
Lack of association of GPX1 and MnSOD genes with symptom severity and response to clozapine treatment in schizophrenia subjects.
Human psychopharmacology 2009;24(8):676-9.
2009: Clement Zai; Arun K Tiwari; Nicole King; Vincenzo De Luca; Daniel J Mueller; Sajid Shaikh; Gregory W H Wong; Herbert Y Meltzer; Jeffrey A Lieberman; James L Kennedy
Association study of the gamma-aminobutyric acid type a receptor gamma2 subunit gene with schizophrenia.
Schizophrenia research 2009;114(1-3):33-8.
2009: Clement Zai; Arun K Tiwari; Vincenzo S Basile; Vincenzo De Luca; Daniel J Müller; Nicole King; A N Voineskos; Gary Remington; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; James L Kennedy
Association study of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patients.
The pharmacogenomics journal 2009;9(3):168-74.
2009: Vincenzo De Luca; Renan Souza; Emanuella Viggiano; Clement Zai; Takahiro Shinkai; Jeffrey A Lieberman; Steven G Potkin; Herbert Y Meltzer; Gary Remington; James L Kennedy
MDR1 gene in tardive dyskinesia scale scores: comparison of strategies for quantitative trait haplotype analysis.
Schizophrenia research 2009;110(1-3):200-1.
2009: Clement Zai; Arun K Tiwari; Vincenzo De Luca; Daniel J Müller; Natalie Bulgin; Rudi Hwang; Gwyneth C Zai; Nicole King; Aristotle N Voineskos; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; Gary Remington; James L Kennedy
Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2009;19(5):317-28.
2008: Clement Zai; Marco A Romano-Silva; Rudi Hwang; Gwyneth C Zai; Vincenzo Deluca; Daniel J Müller; Nicole King; Aristotle N Voineskos; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; Gary Remington; James L Kennedy
Genetic study of eight AKT1 gene polymorphisms and their interaction with DRD2 gene polymorphisms in tardive dyskinesia.
Schizophrenia research 2008;106(2-3):248-52.
2007: J Renou; Vincenzo De Luca; Clement Zai; Natalie Bulgin; Gary Remington; Herbert Y Meltzer; Jeffrey A Lieberman; B Le Foll; James L Kennedy
Multiple variants of the DRD3, but not BDNF gene, influence age-at-onset of schizophrenia.
Molecular psychiatry 2007;12(12):1058-60.
2007: Clement Zai; Rudi Hwang; Vincenzo De Luca; Daniel J Müller; Nicole King; Gwyneth C Zai; Gary Remington; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; James L Kennedy
Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2007;10(5):639-51.
2007: Rudi Hwang; Takahiro Shinkai; Vincenzo De Luca; Xingqun Ni; Steven G Potkin; Jeffrey A Lieberman; Herbert Y Meltzer; James L Kennedy
Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response.
Journal of psychopharmacology (Oxford, England) 2007;21(7):718-27.
2006: Gwyneth Zai; Daniel J Müller; Jan Volavka; Pal Czobor; Jeffrey A Lieberman; Herbert Y Meltzer; James L Kennedy
Family and case-control association study of the tumor necrosis factor-alpha (TNF-alpha) gene with schizophrenia and response to antipsychotic medication.
Psychopharmacology 2006;188(2):171-82.
2005: Robert B Zipursky; Hongbin Gu; Alan I Green; Diana O Perkins; Mauricio Tohen; Joseph P McEvoy; Stephen M Strakowski; Tonmoy Sharma; René S Kahn; Raquel E Gur; Gary D Tollefson; Jeffrey A Lieberman
Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol.
The British journal of psychiatry : the journal of mental science 2005;187():537-43.
2005: Takahiro Shinkai; Vincenzo De Luca; Rudi Hwang; Chima Matsumoto; Hiroko Hori; Osamu Ohmori; Gary Remington; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; Jun Nakamura; James L Kennedy
Association study between a functional glutathione S-transferase (GSTP1) gene polymorphism (Ile105Val) and tardive dyskinesia.
Neuroscience letters 2005;388(2):116-20.
2005: Daniel J Müller; Vincenzo De Luca; Tricia Sicard; Nicole King; Rudi Hwang; Jan Volavka; Pal Czobor; Brian Sheitman; Jean-Pierre Lindenmayer; Leslie Citrome; Joseph P McEvoy; Jeffrey A Lieberman; Herbert Y Meltzer; James L Kennedy
Suggestive association between the C825T polymorphism of the G-protein beta3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2005;15(5):525-31.
2005: Rudi Hwang; Takahiro Shinkai; Vincenzo De Luca; Daniel J Müller; Xingqun Ni; Fabio Macciardi; Steven G Potkin; Jeffrey A Lieberman; Herbert Y Meltzer; James L Kennedy
Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations.
Psychopharmacology 2005;181(1):179-87.
2005: Daniel J Müller; Tim Klempan; Vincenzo De Luca; Tricia Sicard; Jan Volavka; Pal Czobor; Brian Sheitman; Jean-Pierre Lindenmayer; Leslie Citrome; Joseph P McEvoy; Jeffrey A Lieberman; William Honer; James L Kennedy
The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia.
Neuroscience letters 2005;379(2):81-9.
2005: Vincenzo De Luca; John B Vincent; Daniel J Müller; Rudi Hwang; Takahiro Shinkai; Jan Volavka; Pal Czobor; Brian Sheitman; Jean-Pierre Lindenmayer; Leslie Citrome; Joseph P McEvoy; Jeffrey A Lieberman; James L Kennedy
Identification of a naturally occurring 21 bp deletion in alpha 2c noradrenergic receptor gene and cognitive correlates to antipsychotic treatment.
Pharmacological research : the official journal of the Italian Pharmacological Society 2005;51(4):381-4.
2001: Vincenzo S Basile; Vural Ozdemir; Mario Masellis; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; Fabio Macciardi; Arturas Petronis; James L Kennedy
Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia.
Molecular psychiatry 2001;6(2):230-4.
2001: Mario Masellis; Vincenzo S Basile; Herbert Y Meltzer; Jeffrey A Lieberman; Serge Sevy; David Goldman; M W Hamblin; Fabio Macciardi; James L Kennedy
Lack of association between the T-->C 267 serotonin 5-HT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia.
Schizophrenia research 2001;47(1):49-58.
2000: Vincenzo S Basile; Vural Ozdemir; Mario Masellis; M L Walker; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; Gustavo Alva; Werner Kalow; Fabio Macciardi; James L Kennedy
A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia.
Molecular psychiatry 2000;5(4):410-7.
1999: Vincenzo S Basile; Mario Masellis; F Badri; A D Paterson; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; Fabio Macciardi; James L Kennedy
Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1999;21(1):17-27.
1998: Mario Masellis; Vincenzo S Basile; Herbert Y Meltzer; Jeffrey A Lieberman; Serge Sevy; Fabio Macciardi; P Cola; A Howard; F Badri; M M Nöthen; Werner Kalow; James L Kennedy
Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1998;19(2):123-32.
1996: Andrew D Paterson; D J Ying; Arturas Petronis; O Schoots; Jeffrey A Lieberman; Hubert H M Van Tol; James L Kennedy
A PstI restriction fragment length polymorphism in the 5' untranslated region of DRD4 is not associated with schizophrenia.
Psychiatric genetics 1996;6(4):191-3.
1995: Mario Masellis; Andrew D Paterson; F Badri; Jeffrey A Lieberman; Herbert Y Meltzer; P Cavazzoni; James L Kennedy
Genetic variation of 5-HT2A receptor and response to clozapine.
Lancet 1995;346(8982):1108.